Veri MedTech Holdings, Inc. (VRHI) stock & equity tools

Veri Medtech Holdings (OTC: VRHI) operates Veriheal, a telehealth platform founded in 2017 by Joshua Green and Samuel Adetunji that connects patients with state-licensed physicians for medical marijuana card certifications across multiple U.S. states. The Denver-based company has processed over 400,000 patient approvals through a network of roughly 400 physicians and reported cumulative revenue exceeding $100 million since inception, per a May 2025 company announcement. Veri Medtech filed an S-1 with the SEC in November 2025 seeking a $15 million Nasdaq uplisting at $4 per share, disclosing a going-concern risk tied to working capital deficits.

Sources: renaissancecapital.com · globenewswire.com

Equity comp at Veri MedTech Holdings, Inc.

• OTC Pink Sheet micro-cap (ticker VRHI) with a pending Nasdaq uplisting through a small follow-on offering. The equity plan permits both options and RSUs, though concrete grant terms are not publicly disclosed in detail. Liquidity is currently constrained by thin OTC trading volume rather than a vesting trigger.
• RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.

Sources: sec.gov

Researched 2026-05-11.